Literature DB >> 16631477

A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1).

Biljana Todorić-Zivanović1, Dragomir Marisavljević, Cecilia Surace, Vesna Cemerikić, Olivera Marković, Koviljka Krtolica, Zeljka Tatomirović, Bojana Cikota, Zvonko Magić, Mariano Rocchi.   

Abstract

Chronic myeloid leukemia (CML) is a clonal malignant disorder of a pluripotent hematopoetic stem cell characterized by the presence of the Philadelphia (Ph) chromosome in more than 90% of patients. Cryptic or "masked" BCR/ABL gene rearrangements may be found in cases with a normal karyotype and in cases with the complex karyotype, in which typical t(9;22) is not visible at the microscopic level. Those rearrangements can now be detected by fluorescence in situ hybridization. Here, we report on a novel and complex Ph chromosome-negative CML case with a t(6;9)(p21;q34.1) in which the BCR/ABL fusion gene is located at 6p21.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631477     DOI: 10.1016/j.cancergencyto.2005.11.008

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

1.  Molecular cytogenetic characterization of Philadelphia-negative rearrangements in chronic myeloid leukemia patients.

Authors:  Ayda Bennour; Hatem Bellâaj; Yosra Ben Youssef; Moez Elloumi; Abderrahim Khelif; Ali Saad; Halima Sennana
Journal:  J Cancer Res Clin Oncol       Date:  2011-07-08       Impact factor: 4.553

2.  Molecular cytogenetic study of derivative chromosome 9 deletion in chronic myeloid leukemia patients.

Authors:  Ayda Bennour; Ines Ouahchi; Yosra Ben Youssef; Monia Zaier; Mohamed Adnéne Laatiri; Imed Harrabi; Balkis Meddeb; Moez Elloumi; Abderrahim Khelif; Ali Saad; Halima Sennana
Journal:  Med Oncol       Date:  2011-04-03       Impact factor: 3.064

3.  CEBPA-mediated upregulation of the lncRNA PLIN2 promotes the development of chronic myelogenous leukemia via the GSK3 and Wnt/β-catenin signaling pathways.

Authors:  Chengming Sun; Shuping Luan; Guili Zhang; Na Wang; Huiyuan Shao; Caifu Luan
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

4.  Complex translocation involving four chromosomes in a novel Philadelphia-positive chronic myeloid leukemia case.

Authors:  Walid Al-Achkar; Abdulsamad Wafa; Thomas Liehr
Journal:  Oncol Lett       Date:  2011-01-21       Impact factor: 2.967

5.  FISH mapping of Philadelphia negative BCR/ABL1 positive CML.

Authors:  Anna Virgili; Diana Brazma; Alistair G Reid; Julie Howard-Reeves; Mikel Valgañón; Anastasios Chanalaris; Valeria As De Melo; David Marin; Jane F Apperley; Colin Grace; Ellie P Nacheva
Journal:  Mol Cytogenet       Date:  2008-07-18       Impact factor: 2.009

6.  MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via down-regulation of GADD45α.

Authors:  Peng Yang; Fang Ni; Rui-Qing Deng; Guo Qiang; Hua Zhao; Ming-Zhen Yang; Xin-Yi Wang; You-Zhi Xu; Li Chen; Dan-Lei Chen; Zhi-Jun Chen; Li-Xin Kan; Si-Ying Wang
Journal:  Mol Cancer       Date:  2015-11-06       Impact factor: 27.401

7.  Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis.

Authors:  Andreas Hochhaus; Franҫois-Xavier Mahon; Philipp le Coutre; Ljubomir Petrov; Jeroen J W M Janssen; Nicholas C P Cross; Delphine Rea; Fausto Castagnetti; Andrzej Hellmann; Gianantonio Rosti; Norbert Gattermann; Maria Liz Paciello Coronel; Maria Asuncion Echeveste Gutierrez; Valentin Garcia-Gutierrez; Beatrice Vincenzi; Luca Dezzani; Francis J Giles
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-21       Impact factor: 4.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.